CAPOGROSSO, Roberta Francesca
 Distribuzione geografica
Continente #
NA - Nord America 809
EU - Europa 119
AS - Asia 56
OC - Oceania 1
Totale 985
Nazione #
US - Stati Uniti d'America 808
IT - Italia 55
CN - Cina 45
SE - Svezia 31
FI - Finlandia 9
GB - Regno Unito 7
VN - Vietnam 4
BE - Belgio 3
DE - Germania 3
FR - Francia 3
IN - India 3
NL - Olanda 3
UA - Ucraina 3
IE - Irlanda 2
JP - Giappone 2
AU - Australia 1
CA - Canada 1
HK - Hong Kong 1
SG - Singapore 1
Totale 985
Città #
Fairfield 132
Woodbridge 94
Houston 81
Chandler 79
Ashburn 74
Cambridge 55
Seattle 48
Wilmington 39
Nyköping 29
Ann Arbor 28
Bari 26
New York 18
Beijing 16
Roxbury 9
Inglewood 8
Lawrence 7
Des Moines 6
Jacksonville 6
Shenyang 6
Nanchang 5
Nanjing 5
Redwood City 5
Sennori 5
Brooklyn 4
Dong Ket 4
Brussels 3
Helsinki 3
London 3
San Diego 3
San Mateo 3
Tianjin 3
Dearborn 2
Dublin 2
Hebei 2
Leawood 2
Los Angeles 2
Monmouth Junction 2
Princeton 2
Pune 2
Seveso 2
Boardman 1
Changsha 1
Chicago 1
Fort Erie 1
Haikou 1
Hefei 1
Indiana 1
Jinan 1
Las Vegas 1
Liverpool 1
Norma 1
Nürnberg 1
Rome 1
San Francisco 1
Sassari 1
Shanghai 1
Shaoxing 1
Sydney 1
Torino 1
Tsuen Wan 1
Valenzano 1
Washington 1
Wuhan 1
Totale 848
Nome #
Effects of Nandrolone in the counteraction of skeletal muscle atrophy in a mouse model of muscle disuse: molecular biology and functional evaluation 135
Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of Duchenne muscular dystrophy: a comparison with the gold standard, α-methyl prednisolone. 126
Contractile efficiency of dystrophic mdx mouse muscle: In vivo and ex vivo assessment of adaptation to exercise of functional end points 120
Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy 109
Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy. 107
A long-term treatment with taurine prevents cardiac dysfunction in mdx mice 95
null 92
Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies 89
null 68
null 61
GLPG0492, a novel selective androgen receptor modulator, improves muscle performance in the exercised-mdx mouse model of muscular dystrophy 25
Angiotensin II modulates mouse skeletal muscle resting conductance to chloride and potassium ions and calcium homeostasis via the AT1 receptor and NADPH oxidase. 17
Gene expression in mdx mouse muscle in relation to age and exercise: aberrant mechanical-metabolic coupling and implications for pre-clinical studies in duchenne muscular dystrophy 17
Totale 1.061
Categoria #
all - tutte 3.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.524


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201974 0 0 0 0 0 0 0 0 0 0 38 36
2019/2020276 36 17 11 33 26 19 24 33 29 20 19 9
2020/2021250 15 14 9 38 20 11 17 10 13 58 33 12
2021/202287 4 4 2 1 0 11 4 2 9 12 15 23
2022/2023166 9 24 11 19 19 24 1 19 28 1 9 2
2023/202466 5 10 2 4 7 22 1 10 0 5 0 0
Totale 1.061